RxDoctor Payments Data

Adeola Fakolade, MD

Family Medicine · Ashtabula, OHNPI 1437530235

Payments from drug & device makers

$982in general payments, 2019–2025

Across 63 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$220
  • Novo Nordisk$128
  • Pfizer$125
  • AstraZeneca$103
  • Abbott$82
  • Amgen$75
  • plus $250 from 9 others

What the payments were for

  • Food & beverage$982100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$982 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$66,911
Medicare patients
184
Services billed
779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$121,870
JardianceEmpagliflozin77$107,588
EliquisApixaban58$54,980
MounjaroTirzepatide18$30,701
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$29,357
RybelsusSemaglutide14$28,372
TrulicityDulaglutide18$27,392
FarxigaDapagliflozin Propanediol31$25,549
JanuviaSitagliptin Phosphate26$19,157
Lantus SolostarInsulin Glargine,hum.Rec.Anlog72$11,557
Victoza 3-PakLiraglutide14$8,497
TrintellixVortioxetine Hydrobromide12$6,294
BrilintaTicagrelor12$5,324
Insulin Lispro Kwikpen U-100Insulin Lispro16$5,163
Breo ElliptaFluticasone/Vilanterol14$4,571

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$128$150,24286 claims
Lilly USA, LLCMounjaro, Trulicity$220$58,09336 claims
PfizerEliquis$125$54,98058 claims
AstraZenecaFarxiga, Brilinta$103$30,87343 claims
MerckJanuvia$26$19,15726 claims
AbbVieSynthroid$48$1,71547 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Ashtabula

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →